MedTrace Logo

Effects of Modified Constraint-induced Movement Therapy With and Without Electrical Stimulation in Erb's Palsy

NCT06303427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-10-15

No results posted yet for this study

Summary

ERB's palsy is an injury of upper section of the brachial plexus (C5-6) leading to an internally rotated and adducted shoulder and a pronated forearm. Modified constraint-induced movement therapy improves the functionality of the affected limb, while electrical stimulation helps in the improvement of active range of motion and muscle strength in ERB's palsy patients. This study aims to investigate the effects of modified constraint-induced movement therapy with and without electrical stimulation on range of motion, muscle strength, and motor functions in patients with ERB's Palsy.

Conditions

  • Erb's Palsy

Interventions

OTHER

Modified constraint-induced movement therapy

The unaffected arm will be restricted by using an upper extremity sling that will strap to the child's trunk with a distal end fastened to prevent the movement of the unaffected limb. The modified constraint-induced movement therapy will include these exercises. 1. Playing with ball. 2. Playing with modeling clay. 3. Playing with LEGOS (building towers or different shapes from the toy bricks). 4. Tearing a paper towel from a roll. 5. Holding and eating biscuits. 6. Eating with a spoon. 7. Drinking from a glass. 8. Combing hair. 9. Brushing teeth. 10. Making bubbles using a bubble blower. 11. Pulling a toy. 12. Placing a hat or piece of cloth on the head. 13. Applying lotion to the trained caregiver.

OTHER

Electrical stimulation

The participants in this group will first receive a 20-minute session of electrical stimulation (on time of 10 s, off time of 30 s, pulse rate of 35 Hz, the pulse width of 300 µs).

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Muhammad Kashif, PhD-PT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-15
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06303427 on ClinicalTrials.gov